Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Prostate Cancer: How Doctors Check You
Prostate Cancer: How Doctors Check You 4

Did you know that 1 in 7 men will be diagnosed with prostate cancer during their lifetime?

Healthcare providers play a vital role in the early detection and treatment of prostate cancer. A urologist is essential in this process. They use a prostate exam and other methods to check for cancer.

Knowing the signs of prostate cancer is the first step. Our team is here to help and guide you through the diagnosis.

Key Takeaways

  • Understanding the risk of prostate cancer is key for men’s health.
  • A urologist is the specialist who checks for signs of prostate cancer.
  • A prostate exam is a key diagnostic method used by urologists.
  • Recognizing prostate cancer symptoms is vital for early detection.
  • Early diagnosis significantly improves treatment outcomes.
  • Regular check-ups with a urologist can help in early detection.

Understanding Prostate Cancer

Prostate Cancer: How Doctors Check You
Prostate Cancer: How Doctors Check You 5

Prostate cancer is when abnormal cells grow out of control in the prostate gland. This can form a tumor, which might or might not be cancerous. Knowing the basics of prostate cancer helps us understand how it’s diagnosed and treated.

What is prostate cancer?

Prostate cancer starts when cells in the prostate gland grow too much. The prostate gland is a small gland in men that makes fluid for semen. If cancer cells spread, it can be very dangerous.

Risk factors associated with prostate cancer

Many things can raise your risk of getting prostate cancer. Getting older is a big risk, with most cases in men over 65. If your family has had prostate cancer, you’re more likely to get it too. Being African American also increases your risk. Other factors include genetic changes and lifestyle choices.

Stages of prostate cancer

Prostate cancer goes through different stages. It starts in the prostate and can spread to other parts of the body. Knowing the stage is key to picking the right treatment. The stages are based on the tumor size, if lymph nodes are involved, and if it has spread.

Importance of Early Detection

Prostate Cancer: How Doctors Check You
Prostate Cancer: How Doctors Check You 6

Early detection of prostate cancer greatly improves treatment chances. A timely diagnosis can significantly impact patient care and survival rates. We will look into why early detection is key and the survival rate statistics.

Why early detection matters

Early detection leads to timely treatment, which boosts success rates. Early detection of prostate cancer increases the chances of successful treatment, leading to better outcomes. This is vital because early-stage cancer often shows no symptoms, making regular screenings essential for those at high risk.

Statistics on survival rates

These statistics show the progress in medical science and the value of proactive health monitoring.

Initial Screening Methods

Diagnosing prostate cancer begins with understanding the first steps. We use these methods to spot problems early. This makes it easier to treat them before symptoms show up.

The Role of PSA Testing

PSA testing checks the prostate-specific antigen in your blood. High levels might mean prostate cancer, but could also point to other issues. It’s a first step to see who needs more tests.

The PSA test alone can’t tell if you have cancer. But, when used with other tests, it helps make a more accurate diagnosis.

Digital Rectal Exam (DRE) Overview

A digital rectal exam lets a healthcare provider feel your prostate gland for any oddities. This can show if there’s something that might be cancer.

In a DRE, the doctor checks the prostate’s size, shape, and feel. It might be a bit uncomfortable, but it’s fast and very helpful.

Screening Method

Purpose

What It Involves

PSA Testing

Measures PSA levels in the blood

A blood test to check for elevated PSA levels

Digital Rectal Exam (DRE)

Checks the prostate gland for abnormalities

A healthcare provider feels the prostate gland through the rectum

PSA testing and DRE are key first steps. They help us find who needs more tests. This way, we can catch prostate cancer early, when it’s easier to treat.

Transrectal Ultrasound

Transrectal ultrasound, or TRUS, is a way doctors see the prostate gland. It’s key for finding problems in the prostate.

How Ultrasound is Used in Detection

Transrectal ultrasound sends high-frequency sound waves to the prostate. These waves create detailed images. The probe goes into the rectum to send these waves and capture images.

What to Expect During the Procedure

Patients lie on their side with knees up during the ultrasound. The probe is inserted into the rectum. Sound waves are sent to the prostate to get images.

The whole thing takes about 30 minutes. Some discomfort is possible, but it’s usually mild.

The benefits of transrectal ultrasound include:

  • Accurate Imaging: It gives clear images of the prostate gland.
  • Minimally Invasive: It’s not very uncomfortable and doesn’t need surgery.
  • Diagnostic Value: It helps find problems and guide more tests like biopsies.

Transrectal ultrasound helps doctors understand the prostate’s health. It helps find prostate cancer early.

Biopsy Procedures

A biopsy is key in diagnosing prostate cancer. It helps us find out if cancer is present and how aggressive it is. We take tissue samples from the prostate to check for cancer cells.

Types of Prostate Biopsies

There are different ways to do a prostate biopsy. The most common is the transrectal ultrasound-guided biopsy. This method uses a needle guided through the rectum into the prostate. Another way is the transperineal biopsy, which goes through the perineum, the area between the scrotum and anus. The choice depends on the patient’s health and where the cancer might be.

How Biopsies Confirm Diagnosis

The tissue samples are looked at under a microscope for cancer. If cancer is found, we use the Gleason score to see how aggressive it is. The score ranges from 2 to 10, with higher scores meaning more aggressive cancer.

This score helps us decide the best treatment. By looking at the biopsy results, we can confirm prostate cancer and plan a treatment that fits the patient.

Imaging Tests for Prostate Cancer

Doctors use advanced imaging tests to understand prostate cancer. These tests help figure out how far the disease has spread. They are key for planning the best treatment.

Imaging tests let us see the prostate gland and the tissues around it. This helps in making a more accurate diagnosis. MRI scans and CT scans are two common tests used.

MRI Scans: What They Reveal

MRI scans show detailed images of the prostate and nearby tissues. They are great for finding out the size and location of tumors. They also help see if the cancer has spread.

We use MRI scans to plan for biopsies or treatments. The detailed images help us stage the cancer accurately. This is important for choosing the right treatment.

CT Scans: Understanding the Process

CT scans use X-rays to create detailed images of the body. For prostate cancer, they help see if the cancer has spread to lymph nodes or other areas.

During a CT scan, we might use a contrast agent. This makes the areas of interest stand out. The test is quick and painless. It gives us important information for planning treatment.

Both MRI and CT scans are important for diagnosing and staging prostate cancer. They help us understand the disease better. This is key for creating an effective treatment plan.

Genetic Testing and Prostate Cancer

Genetic testing is key in fighting prostate cancer. It helps us spot who’s at higher risk. This way, we can plan better treatments.

Reasons for Considering Genetic Testing

Genetic tests are suggested for those with a family history of prostate cancer. This is true if many relatives have had it or were young when diagnosed. We also test those with certain genetic mutations that raise prostate cancer risk.

For example, BRCA1 and BRCA2 genes are linked to breast and ovarian cancer. But they also up the risk of prostate cancer. Finding these mutations helps us understand the risk better. This guides our decisions on screening and prevention.

Common Genetic Markers

Many genetic markers are linked to a higher prostate cancer risk. Some key ones are:

  • BRCA1 and BRCA2: Mutations in these genes raise the risk of prostate cancer, among others.
  • HOXB13: This gene’s mutations are tied to a higher prostate cancer risk, mainly in families with a history.
  • Other genes: Genes like MLH1, MSH2, MSH6, and PMS2 are linked to Lynch syndrome. They also increase the risk.

Genetic Marker

Description

Association with Prostate Cancer

BRCA1

Tumor suppressor gene

Increased risk of prostate cancer

BRCA2

Tumor suppressor gene

Increased risk of prostate cancer, mainly aggressive forms

HOXB13

Homeobox gene involved in prostate development

Increased risk, mainly in families

MLH1, MSH2, MSH6, PMS2

DNA mismatch repair genes

Linked to Lynch syndrome; may raise prostate cancer risk

Knowing about these genetic markers helps us find those at higher risk. It lets us plan better screening and prevention. So, genetic testing is vital in managing prostate cancer today.

Follow-Up Testing and Monitoring

Follow-up testing is key in treating and managing prostate cancer. After a diagnosis, patients need ongoing care. This helps monitor the disease’s progress and adjust treatment plans.

Importance of Follow-Up Tests

Regular follow-up tests are vital for spotting any changes in prostate cancer. This allows for timely adjustments to treatment plans. Early detection of any changes can significantly impact the outcome of the treatment.

Healthcare providers use various methods during follow-up tests. These include PSA testing and imaging tests. These tests help understand the cancer’s behavior and guide treatment decisions.

Scheduling Regular Check-Ups

Scheduling regular check-ups is vital in managing prostate cancer. We advise patients to work closely with their healthcare providers. Consistency is key to ensuring that any changes are caught early.

The frequency of follow-up tests varies based on several factors. These include the cancer’s stage, treatment, and the patient’s health. It’s important for patients to stick to their scheduled follow-up appointments for continuous monitoring and care.

By focusing on follow-up testing and monitoring, we can effectively manage prostate cancer. This improves outcomes and quality of life for our patients.

Understanding Test Results

After getting tests for prostate cancer, it’s key to understand the results. This helps decide what to do next. We’ll explain what these results mean and how they affect treatment choices.

Interpreting PSA Levels

PSA (Prostate-Specific Antigen) levels are important for prostate health. A high PSA level might mean prostate cancer, but it’s not the only sign. Usually, a PSA under 4 ng/mL is normal. Yet, higher levels can raise cancer risk.

Here’s a simple guide to PSA levels:

PSA Level (ng/mL)

Interpretation

0-4

Generally considered within the normal range, but cancer can be present.

4-10

May show a higher risk of prostate cancer; more tests are often needed.

Above 10

Strongly suggests prostate cancer; a biopsy is usually advised.

What Biopsy Results Mean

Biopsy results confirm cancer and give a Gleason score. This score shows how aggressive the cancer is. The Gleason score ranges from 2 to 10, with higher scores meaning more aggressive cancer.

Knowing your Gleason score is key for understanding cancer severity. It helps choose the right treatment. Here’s a quick guide:

Gleason Score

Cancer Aggressiveness

2-6

Low to moderate aggressiveness; often monitored or treated with less aggressive therapies.

7

Moderate aggressiveness; treatment plans are often more aggressive.

8-10

High aggressiveness; typically requires more aggressive treatment approaches.

By knowing your test results, including PSA levels and biopsy outcomes, you and your doctor can make the best treatment plan.

Risks and Side Effects of Testing

Prostate cancer screening is key for early detection. But, it’s also vital to know the risks and side effects of these tests. Many patients feel anxious about diagnostic testing.

Common Side Effects of Biopsy Procedures

Biopsy procedures are generally safe but can have side effects. These include:

  • Pain or discomfort during or after the procedure
  • Bleeding or hematoma
  • Infection
  • Temporary difficulty urinating

Most side effects are temporary and can be managed with proper care.

The Psychological Impact of Prostate Cancer Testing

Prostate cancer testing can deeply affect patients’ minds. They worry about the diagnosis, fear the unknown, and are concerned about the procedure.

Healthcare providers should offer support and guidance. This helps reduce these worries.

Potential Risks/Side Effects

Description

Management/Prevention

Pain/Discomfort

Pain experienced during or after biopsy

Local anesthesia, pain management medication

Bleeding/Hematoma

Bleeding or bruising after biopsy

Monitoring, applying pressure, medication

Infection

Risk of infection post-biopsy

Antibiotics, proper wound care

Psychological Impact

Anxiety, fear related to testing and diagnosis

Counseling, support groups, clear communication

Knowing the risks and side effects of prostate cancer testing is key. It helps patients make informed decisions. By understanding these issues, patients can prepare better and talk about their concerns with their healthcare provider.

Treatment Options After Diagnosis

After finding out you have prostate cancer, it’s important to know your treatment options. This journey involves looking at many factors that affect your treatment choice. We’re here to help you understand this process.

Overview of Treatment Choices

Prostate cancer treatment varies from person to person. You might choose surgery, radiation therapy, or active surveillance. Each option has its own good points and possible downsides.

  • Surgery: This is for patients with early-stage prostate cancer. It means removing the prostate gland.
  • Radiation Therapy: This uses high-energy rays to kill cancer cells. It’s for those with early or slightly more advanced cancer.
  • Active Surveillance: This is for those with low-risk cancer. It means watching the cancer closely with tests, not treating right away.

Factors Influencing Treatment Decisions

Choosing a treatment depends on several things. These include the stage and aggressiveness of the cancer and patient preferences. Your overall health, age, and the side effects of treatment also matter.

Deciding on treatment can be tough. It’s key to talk about your options with your doctor. This way, you can weigh the pros and cons of each choice. This helps you make a decision that fits your needs.

Resources for Patients and Families

Getting a prostate cancer diagnosis can be tough for patients and their families. We know how important it is to offer full support during this hard time. There are many resources to help you understand and deal with the diagnosis and treatment.

Support and Guidance

Support groups let patients meet others who have gone through similar things. This creates a sense of community and understanding. Counseling services are also there to offer emotional support and guidance during treatment.

Empowering through Education

Learning about prostate cancer is key to empowering patients and their families. We offer access to reliable educational resources. These help patients make informed decisions about their treatment.

Using these resources, patients and their families can face the challenges of prostate cancer better. They get the support and care they need on their journey.

FAQ

What is prostate cancer and how is it diagnosed?

Prostate cancer is a type of cancer that affects the prostate gland. We use tests like PSA testing, digital rectal exams, and biopsies to diagnose it.

What are the risk factors associated with prostate cancer?

Risk factors include age, family history, ethnicity, and genetic mutations. Knowing these helps us decide when to screen you.

Why is early detection of prostate cancer important?

Finding prostate cancer early can greatly improve treatment success and survival chances. Early detection leads to better management of the disease.

What is the role of PSA testing in prostate cancer screening?

PSA testing checks the prostate-specific antigen in your blood. High levels might mean cancer, but other issues can also cause it.

What is a digital rectal exam (DRE) and how is it performed?

A DRE is a physical exam where a doctor checks the prostate gland. It’s a key part of screening for prostate cancer.

What is a transrectal ultrasound and how is it used in prostate cancer detection?

A transrectal ultrasound uses sound waves to see the prostate gland. It guides biopsies and checks for size and abnormalities.

What are the different types of prostate biopsies?

There are several types, like transrectal and transperineal biopsies. These remove tissue samples for examination.

How is the Gleason score used in prostate cancer diagnosis?

The Gleason score rates cancer aggressiveness based on tissue analysis. It helps decide the cancer grade and treatment.

What imaging tests are used in prostate cancer diagnosis and staging?

Tests like MRI and CT scans help stage and plan treatment. They show detailed images of the prostate and surrounding areas.

What is the significance of genetic testing in prostate cancer?

Genetic testing finds genetic mutations that may raise cancer risk. It helps in assessing and managing risk.

Why is follow-up testing and monitoring important in prostate cancer management?

Regular tests and monitoring track disease progress and treatment response. They allow for timely treatment plan adjustments.

How do I interpret my PSA test results?

PSA results should be seen in the context of your health and other findings. High PSA levels might mean cancer, but other issues can also cause it.

What are the risks and side effects of prostate cancer testing?

Testing can cause discomfort, infection, and emotional impact. We work to minimize these risks.

What treatment options are available for prostate cancer?

Options include surgery, radiation, active surveillance, and hormone therapy. The best choice depends on cancer stage, aggressiveness, and your health.

What resources are available to support patients and families affected by prostate cancer?

We offer support groups, counseling, and educational materials. These help patients and families deal with prostate cancer challenges.

Reference

Centers for Disease Control and Prevention. Evidence-Based Medical Insight. Retrieved from https://www.cdc.gov/prostate-cancer/screening/get-screened.html

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01